Venture Capital

Updated:

LIVEventures

LIVEventures is a Swiss private equity firm targeting early-stage seed and start-up investments from Kaiseraugst.

LIVEventures logo

LIVEventures

LIVEventures is a venture capital firm that invests in pharma, medical devices, and start-up businesses. It has made one investment to date. LIVEventures invested in Lymphatica Medtech as part of their Series A funding on December 03, 2020.

General information

Firm type

Venture Capital

Year founded

AUM

Undisclosed

Location

Region

Europe

Country

Switzerland

City

Kaiseraugst

Corporate office

Kaiseraugst, Switzerland

Frequently asked questions

What investment stages does LIVEventures target?

LIVEventures focuses on early-stage equity, specifically seed and start-up rounds. The firm aims to provide initial institutional capital to founding teams. Later-stage or growth equity investments fall outside its stated strategy, per the firm's own characterization.

How does LIVEventures source its deals?

Publicly available information does not detail a specific proprietary sourcing model. As a Swiss boutique, deal flow likely originates through local networks within the DACH region's venture ecosystem. No accelerator partnerships, university affiliations, or structured origination programs are publicly recorded.

Does LIVEventures participate in fund commitments or only direct deals?

The firm's disclosed strategy covers direct early-stage investments. There is no public record of LIVEventures acting as a limited partner in external funds or operating a fund-of-funds allocation program.

Who runs investment decisions at LIVEventures?

The principals and investment committee members of LIVEventures are not publicly disclosed. The firm does not publish biographies of its leadership or investment team on its public-facing presence.

How is LIVEventures structured, and where is it regulated?

LIVEventures operates as a private equity firm domiciled in Switzerland. It is structured as an asset manager without publicly listed securities or exchange-traded fund vehicles. Its regulatory status would fall under Swiss law, though no FINMA registrations or specific exemptions are publicly confirmed for this entity.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Kaiseraugst Venture Capital profiles